The Committee to Advise on Tropical Medicine and Travel (CATMAT) - a reference for Canadian paediatricians.

The Committee to Advise on Tropical Medicine and Travel (CATMAT) is a federal government committee with wide representation in the fields of travel medicine and infectious diseases. They produce evidence-based statements on tropical and travel medicine for Canadian clinicians, including paediatric content ensured by the involvement of paediatric experts and a liaison member from the Canadian Paediatric Society. Links to all of the active statements are provided in the present practice point, with the aim of making Canadian health care providers more aware of this excellent resource.

Increasing the use of influenza vaccines in children with egg allergy.

Administration of inactivated trivalent or quadrivalent influenza vaccines is now believed to be safe for individuals with egg allergy. Unless children have experienced an anaphylactic reaction to a previous dose of influenza vaccine, they can and should be immunized with a full dose of trivalent or quadrivalent inactivated vaccine.

Acute otitis externa.

Acute otitis externa, also known as 'swimmer's ear', is a common disease of children, adolescents and adults. While chronic suppurative otitis media or acute otitis media with tympanostomy tubes or a perforation can cause acute otitis externa, both the infecting organisms and management protocol are different. This practice point focuses solely on managing acute otitis externa, without acute otitis media, tympanostomy tubes or a perforation being present.

Use of influenza vaccines in children with an egg allergy.

Children are at increased risk of morbidity from influenza. Influenza vaccines are grown in eggs, leading to a minute amount of egg protein in their composition. Recent research and new practice parameters spurred by the 2009 global influenza pandemic have challenged the need to withhold influenza vaccine from patients with an egg allergy.

Rectal fluconazole for tinea capitis.

The present report describes a case of tinea capitis in a boy with autistic spectrum disorder and an aversion to oral medications. He refused weekly oral fluconazole and there was a poor response to daily rectal griseofulvin. He tolerated once-weekly rectal fluconazole (10 mg/kg) well and there was an excellent clinical outcome.